Dominick Angiolillo

Showing 1-8 of 8 articles

Coronary interventions

Antithrombotic Therapy after Percutaneous Coronary Intervention of Bifurcation Lesions

Zimarino M, Angiolillo D, Dangas G, Capodanno D, Barbato E, Hahn J, Giustino G, Watanabe H, Costa F, Cuisset T, Rossini R, Sibbing D, Burzotta F, Louvard Y, Shehab A, Renda G, Kimura T, Gwon H, Chen S, Costa R, Koo B, Storey R, Valgimigli M, Mehran R, Stankovic G

September 15, 2020 | 10.4244/EIJ-D-20-00885

De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

Capranzano P, Angiolillo D

August 9, 2019 | 10.4244/EIJV15I6A89

Coronary interventions

Crushed ticagrelor in comatose patients treated with primary percutaneous coronary intervention

Rollini F, Franchi F, Angiolillo D

February 20, 2017 | 10.4244/EIJV12I14A276

Coronary interventions

Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

De Servi S, Crimi G, Calabrò P, Piscione F, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Angiolillo D, Palmerini T

June 20, 2016 | 10.4244/EIJV12I3A51

Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies

Rossini R, Musumeci G, Visconti L, Bramucci E, Castiglioni B, De Servi S, Lettieri C, Lettino M, Piccaluga E, Savonitto S, Trabattoni D, Capodanno D, Buffoli F, Parolari A, Dionigi G, Boni L, Biglioli F, Valdatta L, Droghetti A, Bozzani A, Setacci C, Ravelli P, Crescini C, Staurenghi G, Pietro Scarone P, Francetti L, D’Angelo F, Gadda F, Comel A, Salvi L, Lorini L, Antonelli M, Bovenzi F, Cremonesi A, Angiolillo D, Guagliumi G

May 20, 2014 | 10.4244/EIJV10I1A8

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jimenez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M

July 26, 2013 | 10.4244/EIJV9I3A54

Diabetes mellitus: the scary killer haunting silently

Capodanno D, Angiolillo D

April 12, 2010

Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome

Gomez-Moreno S, Sabaté M, Jimenez-Quevedo P, Vazquez P, Alfonso F, Angiolillo D, Hernández-Antolín R, Moreno R, Banuelos C, Escaned J, Macaya C

August 20, 2006

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

EBC 15th consensus document

Save the date: 19th April at 6pm (CET). Join us on Twitter for the 2nd edition

This Week's JAA's: Deep Learning Model to Detect AMI, Mortality After Bleeding vs MI in CAD Patients...

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

Randomised Comparison between POT and KBT: PROPOT Trial

Yusuke Watanabe et al.

Similar long-term outcome of dissimilar drug-eluting stents: is it time to change the assessment?

Clemens von Birgelen et al.

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

Valvular disease